Search Results - "Rideout, Hardy J"
-
1
Pathological roles of α-synuclein in neurological disorders
Published in Lancet neurology (01-11-2011)“…Summary Substantial genetic, neuropathological, and biochemical evidence implicates the presynaptic neuronal protein α-synuclein in Parkinson's disease and…”
Get full text
Journal Article -
2
The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease
Published in Neurochemical research (01-03-2014)“…Leucine-rich repeat kinase 2 (LRRK2) is a large, widely expressed protein of largely unknown function. Mutations in the gene encoding LRRK2 have been linked to…”
Get full text
Journal Article -
3
LRRK2 Parkinson disease mutations enhance its microtubule association
Published in Human molecular genetics (15-02-2012)“…Dominant missense mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic causes of Parkinson disease (PD) and genome-wide association…”
Get full text
Journal Article -
4
A motif within the armadillo repeat of Parkinson’s-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway
Published in Scientific reports (22-02-2018)“…In experimental models, both in vivo and cellular, over-expression of Parkinson’s linked mutant leucine-rich repeat kinase 2 (LRRK2) is sufficient to induce…”
Get full text
Journal Article -
5
The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease
Published in Frontiers in neuroscience (18-08-2020)“…Evidence is mounting that LRRK2 activity, particularly its kinase activity, is elevated in multiple forms of Parkinson’s disease, both idiopathic as well as…”
Get full text
Journal Article -
6
Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations
Published in PloS one (10-11-2016)“…Despite the plethora of sequence variants in LRRK2, only a few clearly segregate with PD. Even within this group of pathogenic mutations, the phenotypic…”
Get full text
Journal Article -
7
The WD40 domain is required for LRRK2 neurotoxicity
Published in PloS one (24-12-2009)“…Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson disease (PD). LRRK2 contains an "enzymatic core" composed of…”
Get full text
Journal Article -
8
The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease
Published in Biomolecules (Basel, Switzerland) (16-06-2020)“…Biomarkers and disease-modifying therapies are both urgent unmet medical needs in the treatment of Parkinson's disease (PD) and must be developed concurrently…”
Get full text
Journal Article -
9
Longitudinal transcriptomic analysis of mouse sciatic nerve reveals pathways associated with age‐related muscle pathology
Published in Journal of cachexia, sarcopenia and muscle (01-06-2023)“…Background Sarcopenia, the age‐associated decline in skeletal muscle mass and strength, has long been considered a disease of muscle only, but accumulating…”
Get full text
Journal Article -
10
Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts
Published in NPJ Parkinson's Disease (08-06-2022)“…Despite several advances in the field, pharmacodynamic outcome measures reflective of LRRK2 kinase activity in clinical biofluids remain urgently needed. A…”
Get full text
Journal Article -
11
Neuronal death signaling pathways triggered by mutant LRRK2
Published in Biochemical Society transactions (08-02-2017)“…Autosomal dominantly inherited mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease…”
Get more information
Journal Article -
12
Targeted disruption of neuronal 19S proteasome subunits induces the formation of ubiquitinated inclusions in the absence of cell death
Published in Journal of neurochemistry (01-11-2011)“…J. Neurochem. (2011) 119, 630–643. Proteasome‐mediated proteolysis is a major protein degradation mechanism in cells and its dysfunction has been implicated in…”
Get full text
Journal Article -
13
Defining (and blocking) neuronal death in Parkinson’s disease: Does it matter what we call it?
Published in Brain research (15-11-2021)“…•Neuronal loss in Parkinson’s disease can take multiple forms.•Evidence of apoptotic, necroptotic, and pyroptotic signaling exists in PD.•The role of the…”
Get full text
Journal Article -
14
Nurr1: RXRα heterodimer activation as monotherapy for Parkinson’s disease
Published in Proceedings of the National Academy of Sciences - PNAS (11-04-2017)“…Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic (DAergic) neurons in the substantia nigra and…”
Get full text
Journal Article -
15
Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway
Published in Journal of neurochemistry (01-09-2004)“…Proteasomal dysfunction may play a role in a number of neurodegenerative conditions, and in particular Parkinson's disease (PD) and related Lewy body (LB)…”
Get full text
Journal Article -
16
Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk
Published in Journal of Parkinson's disease (01-01-2023)Get full text
Journal Article -
17
The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration
Published in The Journal of neuroscience (28-01-2009)“…Neurodegenerative illnesses such as Parkinson and Alzheimer disease are an increasingly prevalent problem in aging societies, yet no therapies exist that…”
Get full text
Journal Article -
18
Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based Method
Published in Movement disorders (01-11-2020)“…Background Leucine‐rich repeat kinase 2 kinase inhibitors are being vigorously pursued as potential therapeutic options; however, there is a critical need for…”
Get full text
Journal Article -
19
Involvement of macroautophagy in the dissolution of neuronal inclusions
Published in The international journal of biochemistry & cell biology (01-12-2004)“…Ubiquitinated inclusions are a common feature of many neurodegenerative conditions. We have proposed that, at least in part, such inclusions may be formed due…”
Get full text
Journal Article -
20
Synuclein‐1 is selectively up‐regulated in response to nerve growth factor treatment in PC12 cells
Published in Journal of neurochemistry (01-02-2001)“…Mutations in the α‐synuclein gene have recently been identified in families with inherited Parkinson's disease and the protein product of this gene is a…”
Get full text
Journal Article